Affinage

PKP3

Plakophilin-3 · UniProt Q9Y446

Length
797 aa
Mass
87.1 kDa
Annotated
2026-04-28
16 papers in source corpus 8 papers cited in narrative 8 extracted findings

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

PKP3 is a plakophilin family member that functions beyond cell adhesion as a signaling intermediate linking Wnt, MAPK, and necroptosis pathways. PKP3 associates with the β-catenin destruction complex components GSK3β and Axin, is stabilized and translocates to the nucleus upon Wnt ligand stimulation, and activates Wnt-responsive transcription (PMID:34058472). PKP3 also activates downstream MAPK/p38 and mTOR signaling to promote cell proliferation, invasion, and ERCC1 expression (PMID:30527804, PMID:38200443, PMID:37420272), and positively regulates RIPK3/MLKL-dependent necroptosis (PMID:40116080). PKP3 expression is controlled by promoter/gene-body methylation (PMID:34415821) and is post-transcriptionally suppressed by miR-10b-5p, which directly targets its 3′-UTR (PMID:40116080), and by miR-149 (PMID:30144176).

Mechanistic history

Synthesis pass · year-by-year structured walk · 8 steps
  1. 2018 Low

    Establishing that PKP3 is not merely a structural desmosomal protein but an upstream activator of mTOR signaling that promotes cancer cell proliferation, invasion, and autophagy regulation in ovarian cancer.

    Evidence siRNA knockdown and overexpression with pathway inhibitors and proliferation/invasion assays in ovarian cancer cells

    PMID:30527804

    Open questions at the time
    • No direct biochemical interaction between PKP3 and MAPK/mTOR components was demonstrated
    • Single cell-line context (ovarian cancer); generalizability unclear
    • Mechanism by which PKP3 engages MAPK pathway not resolved
  2. 2018 Low

    Identifying PKP3 as a downstream target of miR-149 whose suppression by the carcinogen DNP promotes nasopharyngeal carcinoma cell migration and invasion, providing the first evidence for miRNA-mediated PKP3 regulation.

    Evidence miR-149 inhibitor rescue experiments and western blot in NPC cell lines treated with DNP

    PMID:30144176

    Open questions at the time
    • Direct binding of miR-149 to the PKP3 3′-UTR was not validated by luciferase reporter assay
    • Mechanism linking PKP3 loss to enhanced invasion not delineated
  3. 2021 Medium

    Revealing that PKP3 is a novel component of the canonical Wnt signaling cascade: it associates with the GSK3β/Axin destruction complex, is stabilized by Wnt ligand, translocates to the nucleus, and activates Wnt-responsive transcription—establishing PKP3 as a Wnt-responsive nuclear effector analogous to β-catenin.

    Evidence Co-immunoprecipitation of PKP3 with GSK3β and Axin, Wnt luciferase reporter assay, nuclear localization imaging upon Wnt stimulation or dominant-active LRP6

    PMID:34058472

    Open questions at the time
    • Whether PKP3 directly binds TCF/LEF transcription factors in the nucleus is unknown
    • Not confirmed whether PKP3 is a direct phosphorylation substrate of GSK3β
    • Single lab study; independent replication lacking
  4. 2021 Medium

    Demonstrating that a gene-body sequence within PKP3 possesses methylation-dependent promoter activity in lung epithelial cells, linking epigenetic regulation to PKP3 transcriptional control.

    Evidence Luciferase reporter assays comparing methylated vs. unmethylated PKP3 gene-body constructs in lung epithelial cells; bisulfite sequencing in cystic fibrosis patient blood

    PMID:34415821

    Open questions at the time
    • Whether gene-body methylation regulates endogenous PKP3 protein levels in vivo is not shown
    • Transcription factors responsive to the methylation state of this region are unidentified
  5. 2023 Low

    Extending the PKP3–MAPK axis by showing PKP3 augments ERCC1 expression through MAPK activation in ovarian granulosa cells, and that PKP3 promoter methylation controls this signaling cascade.

    Evidence PKP3 overexpression/knockdown with ERCC1 and MAPK western blot, promoter methylation analysis in granulosa cells

    PMID:37420272

    Open questions at the time
    • No direct biochemical interaction between PKP3 and any MAPK component demonstrated
    • Single cell type; relevance to other tissues unclear
  6. 2024 Low

    Placing PKP3 downstream of FERMT1 and upstream of p38 MAPK in an epistatic signaling axis that drives NSCLC migration and invasion, specifying p38 as the MAPK branch regulated by PKP3.

    Evidence siRNA knockdown of PKP3 reversing FERMT1-induced p38 MAPK activation; Transwell assays in NSCLC cells

    PMID:38200443

    Open questions at the time
    • Direct physical interaction between PKP3 and p38 MAPK or its upstream kinases not shown
    • Whether FERMT1 directly regulates PKP3 transcription or protein stability is unknown
  7. 2025 Medium

    Establishing PKP3 as a positive regulator of RIPK3/MLKL-dependent necroptosis and validating miR-10b-5p as a direct suppressor of PKP3 via its 3′-UTR, linking PKP3 loss to necroptosis evasion and tumor growth in LUAD.

    Evidence Dual luciferase reporter assay confirming miR-10b-5p targeting of PKP3 3′-UTR; PKP3 knockdown phenocopying miR-10b-5p overexpression; RIPK3/MLKL western blot; xenograft model

    PMID:40116080

    Open questions at the time
    • Whether PKP3 directly binds RIPK3 or acts through an intermediary is unknown
    • Mechanism by which PKP3 activates the necroptosis cascade not resolved
    • Single cancer type studied (LUAD)
  8. 2025 Low

    Identifying a circFOXK2/miR-328-5p/PKP3 regulatory axis that promotes NSCLC proliferation and invasion, adding another miRNA-mediated layer of PKP3 post-transcriptional control.

    Evidence Dual luciferase assay for circFOXK2–miR-328-5p interaction; qRT-PCR and functional assays in NSCLC cells

    PMID:41351372

    Open questions at the time
    • Direct targeting of PKP3 3′-UTR by miR-328-5p not independently validated by luciferase assay
    • Whether circFOXK2 regulation of PKP3 occurs in non-cancer contexts is unknown

Open questions

Synthesis pass · forward-looking unresolved questions
  • How PKP3 biochemically activates MAPK/p38 and RIPK3/MLKL pathways—whether through direct binding or adaptor-mediated mechanisms—remains unresolved, as does the structural basis for its interaction with the Wnt destruction complex and whether it acts as a transcriptional co-activator in the nucleus.
  • No structural or reconstituted biochemical data for PKP3 interaction with any signaling partner
  • Whether PKP3 desmosomal and signaling functions are mutually exclusive or coordinated is unknown
  • No in vivo genetic models (knockout mice) characterizing PKP3 physiological function

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0098772 molecular function regulator activity 4
Localization
GO:0005634 nucleus 1 GO:0005886 plasma membrane 1
Pathway
R-HSA-162582 Signal Transduction 4 R-HSA-5357801 Programmed Cell Death 1

Evidence

Reading pass · 8 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2021 PKP3 protein levels are stabilized in response to canonical Wnt ligand or dominant-active LRP6 receptor, similar to beta-catenin and p120-catenin-isoform1; PKP3 associates with GSK3β and Axin (destruction complex components), and its levels are reduced upon overexpression of GSK3β or Axin; PKP3 trans-localizes into the nucleus in response to Wnt-ligand and its exogenous expression stimulates a Wnt reporter. Co-immunoprecipitation (PKP3 with GSK3β and Axin), luciferase Wnt reporter assay, nuclear localization imaging, overexpression and dominant-active receptor constructs Biochemical and biophysical research communications Medium 34058472
2018 PKP3 activates the mTOR pathway via interaction with upstream MAPK pathway components to regulate autophagy and invasion in ovarian cancer; silencing PKP3 decreased proliferation, colony formation, and invasion, while overexpression upregulated these activities. siRNA knockdown, overexpression, pathway inhibitor assays, cell proliferation/invasion assays Biochemical and biophysical research communications Low 30527804
2018 miR-149 directly decreases PKP3 expression; the carcinogen DNP upregulates miR-149 to suppress PKP3, thereby promoting NPC cell proliferation, adhesion, migration, and invasion; inhibition of miR-149 rescued PKP3 levels and blocked these pro-metastatic effects. miR-149 inhibitor rescue experiments, western blot, migration/invasion assays in NPC cell lines Molecular carcinogenesis Low 30144176
2024 FERMT1 upregulates PKP3 expression and activates the p38 MAPK signaling pathway; knockdown of PKP3 counteracts the p38 MAPK activation induced by FERMT1 overexpression, placing PKP3 downstream of FERMT1 and upstream of p38 MAPK in a migration/invasion-promoting axis in NSCLC. siRNA knockdown of PKP3, FERMT1 overexpression, western blot for p38 MAPK pathway components, Transwell migration/invasion assays BMC cancer Low 38200443
2025 miR-10b-5p directly targets the PKP3 3'UTR (validated by dual luciferase reporter assay) to suppress PKP3 expression; reduced PKP3 inhibits the RIPK3/MLKL necroptosis signaling pathway, promoting LUAD cell proliferation and suppressing necroptosis; PKP3 knockdown phenocopies miR-10b-5p overexpression and suppresses RIPK3/MLKL activation. Dual luciferase reporter assay, western blot (RIPK3/MLKL), siRNA knockdown of PKP3, miR-10b-5p overexpression/inhibition, xenograft mouse model Oncology reports Medium 40116080
2025 circFOXK2 acts as a sponge for miR-328-5p to upregulate PKP3, thereby promoting NSCLC cell proliferation, migration, and invasion; direct binding between miR-328-5p and circFOXK2 was validated by dual luciferase reporter assay. Dual luciferase reporter assay, qRT-PCR, CCK-8 proliferation assay, wound healing and Transwell invasion assays Cellular and molecular biology Low 41351372
2021 A sequence in the gene body of PKP3 exhibits methylation-dependent promoter activity in lung epithelial cells, demonstrated by luciferase reporter assays comparing methylated vs. unmethylated constructs; this region is hypermethylated in blood from cystic fibrosis patients with severe phenotype. Luciferase reporter assay with methylated and unmethylated PKP3 gene-body sequence in lung epithelial cells, bisulfite next-generation sequencing Epigenetics Medium 34415821
2023 PKP3 augments ERCC1 expression by activating the MAPK pathway; CFDTW treatment reduces PKP3 expression by enhancing methylation of the PKP3 promoter, which promotes proliferation and reduces apoptosis in ovarian granulosa cells through the PKP3/MAPK/ERCC1 axis. PKP3 overexpression/knockdown, ERCC1 expression analysis, MAPK pathway western blot, promoter methylation analysis, cell proliferation/apoptosis assays Journal of ovarian research Low 37420272

Source papers

Stage 0 corpus · 16 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2003 Immunohistochemical localization of plakophilins (PKP1, PKP2, PKP3, and p0071) in primary oropharyngeal tumors: correlation with clinical parameters. Human pathology 62 12827610
2012 Common polymorphisms in the PKP3-SIGIRR-TMEM16J gene region are associated with susceptibility to tuberculosis. The Journal of infectious diseases 48 22223854
2011 Expression of plakophilins (PKP1, PKP2, and PKP3) in gastric cancers. Diagnostic pathology 40 21194493
2011 Expression of Plakophilins (PKP1, PKP2, and PKP3) in breast cancers. Medical oncology (Northwood, London, England) 34 21947748
2018 PKP3 interactions with MAPK-JNK-ERK1/2-mTOR pathway regulates autophagy and invasion in ovarian cancer. Biochemical and biophysical research communications 32 30527804
2017 First report of blaOXA-181-mediated carbapenem resistance in Aeromonas caviae in association with pKP3-A: Threat for rapid dissemination. Journal of global antimicrobial resistance 25 28743649
2018 Dinitrosopiperazine-decreased PKP3 through upregulating miR-149 participates in nasopharyngeal carcinoma metastasis. Molecular carcinogenesis 16 30144176
2016 Low Vitamin-D Levels Combined with PKP3-SIGIRR-TMEM16J Host Variants Is Associated with Tuberculosis and Death in HIV-Infected and -Exposed Infants. PloS one 15 26872154
2021 A catenin of the plakophilin-subfamily, Pkp3, responds to canonical-Wnt pathway components and signals. Biochemical and biophysical research communications 13 34058472
2024 FERMT1 promotes cell migration and invasion in non-small cell lung cancer via regulating PKP3-mediated activation of p38 MAPK signaling. BMC cancer 10 38200443
2023 Cangfu Daotan Wan alleviates polycystic ovary syndrome with phlegm-dampness syndrome via disruption of the PKP3/ERCC1/MAPK axis. Journal of ovarian research 10 37420272
2021 Analysis of Multiple Human Tumor Cases Reveals the Carcinogenic Effects of PKP3. Journal of healthcare engineering 6 34733461
2025 KRT6A, KRT6B, PKP1, and PKP3 as key hub genes in esophageal cancer: A combined bioinformatics and experimental study. Biochemistry and biophysics reports 4 40612005
2021 Disease-related blood-based differential methylation in cystic fibrosis and its representation in lung cancer revealed a regulatory locus in PKP3 in lung epithelial cells. Epigenetics 3 34415821
2025 Induction of necroptosis in lung adenocarcinoma by miR‑10b‑5p through modulation of the PKP3/RIPK3/MLKL cascade. Oncology reports 2 40116080
2025 CircFOXK2 induces non-small cell lung cancer tumorigenesis through the miR-328-5p/PKP3 axis. Cellular and molecular biology (Noisy-le-Grand, France) 0 41351372